ALK is mutually exclusive and is a potential target for treatment.1 Patients with EML4-ALK-positive lung cancer are non-smokers and relatively younger13–15 and tend to be diagnosed at an advanced stage.13, 15. The gene discussed is ALK; the disease is lung cancer.